(Q41340688)

29 September 2017

title

Use and complications of high-dose disodium etidronate therapy in fibrodysplasia ossificans progressiva (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A411907

fibrodysplasia ossificans progressiva

29 June 2022

main subject

0 references

author name string

J. G. Rogers

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A411907

29 June 2022

J. P. Dorst

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A411907

29 June 2022

W. B. Geho

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A411907

29 June 2022

language of work or name

English

0 references

publication date

1 December 1977

1 reference

full work available at URL

29 September 2017

https://api.elsevier.com/content/article/PII:S0022347677809189?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/S0022-3476(77)80918-9

https://api.elsevier.com/content/article/PII:S0022347677809189?httpAccept=text/plain

24 April 2023

1 reference

https://api.crossref.org/works/10.1016/S0022-3476(77)80918-9

The Journal of Pediatrics

24 April 2023

published in

1 reference

29 September 2017

volume

91

1 reference

29 September 2017

issue

6

1 reference

29 September 2017

page(s)

1011-1014

1 reference

MYOSITIS OSSIFICANS PROGRESSIVA. MINERAL, METABOLIC AND RADIOACTIVE CALCIUM STUDIES OF THE EFFECTS OF HORMONES.

29 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2877%2980918-9

Editorial: Diphosphonate treatment in bone disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2877%2980918-9

Diphosphonates inhibit formation of calcium phosphate crystals in vitro and pathological calcification in vivo.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2877%2980918-9

Diphosphonates in the treatment of myositis ossificans.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2877%2980918-9

Treatment of myositis ossificans progressiva with a diphosphonate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2877%2980918-9

Effect of ethane-1-hydroxy-1,1-diphosphonate (EHDP) and dichloromethylene diphosphonate (Cl 2 MDP) on the calcification and resorption of cartilage and bone in the tibial epiphysis and metaphysis of rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2877%2980918-9

AN ACUTE TERMINAL EPISODE WITH FEVER, NAUSEA, VOMITING, DIARRHEA AND ACROCYANOSIS IN A PATIENT WITH RHEUMATOID ARTHRITIS

7 January 2021

2

1 reference

https://api.crossref.org/works/10.1016/S0022-3476(77)80918-9

Diphosphonates. Experimental and clinical aspects

24 April 2023

6

1 reference

https://api.crossref.org/works/10.1016/S0022-3476(77)80918-9

24 April 2023

Identifiers

1 reference

29 September 2017

1 reference